Aimedis intends to integrate a variety of e-health apps together in one place. Prescriptions, medical records, video conferences, appointments, and second opinions are among them. Aimedis also intends to create NFTs using anonymised medical data. Pharmaceutical businesses can then buy it or utilise it for machine learning. It is envisaged that this may provide patients with new revenue streams. We will have high-quality data – always in the same structure, and dependable – thanks to these NFTs.